9 datasets found
  1. T

    Vascular Biogenics | VBLT - Market Capitalization

    • cdn.tradingeconomics.com
    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 23, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Vascular Biogenics | VBLT - Market Capitalization [Dataset]. https://cdn.tradingeconomics.com/vblt:us:market-capitalization
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    May 23, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 12, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $12.7M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Vascular Biogenics | VBLT - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  2. T

    Vascular Biogenics | VBLT - Debt

    • tradingeconomics.com
    • cdn.tradingeconomics.com
    csv, excel, json, xml
    Updated Mar 15, 2022
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2022). Vascular Biogenics | VBLT - Debt [Dataset]. https://tradingeconomics.com/vblt:us:debt
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Mar 15, 2022
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 20, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $0 in Debt for its fiscal quarter ending in March of 2022. Data for Vascular Biogenics | VBLT - Debt including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  3. T

    Vascular Biogenics | VBLT - Operating Expenses

    • tradingeconomics.com
    • cdn.tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2023). Vascular Biogenics | VBLT - Operating Expenses [Dataset]. https://tradingeconomics.com/vblt:us:operating-expenses
    Explore at:
    json, excel, xml, csvAvailable download formats
    Dataset updated
    Sep 15, 2023
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 23, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $1M in Operating Expenses for its fiscal quarter ending in September of 2023. Data for Vascular Biogenics | VBLT - Operating Expenses including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  4. T

    Vascular Biogenics | VBLT - Ebitda

    • cdn.tradingeconomics.com
    • tradingeconomics.com
    csv, excel, json, xml
    Updated Mar 15, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2023). Vascular Biogenics | VBLT - Ebitda [Dataset]. https://cdn.tradingeconomics.com/vblt:us:ebitda
    Explore at:
    csv, json, xml, excelAvailable download formats
    Dataset updated
    Mar 15, 2023
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 20, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $-3297000 in EBITDA for its fiscal quarter ending in March of 2023. Data for Vascular Biogenics | VBLT - Ebitda including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  5. T

    Vascular Biogenics | VBLT - Sales Revenues

    • cdn.tradingeconomics.com
    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2022). Vascular Biogenics | VBLT - Sales Revenues [Dataset]. https://cdn.tradingeconomics.com/vblt:us:sales
    Explore at:
    xml, csv, json, excelAvailable download formats
    Dataset updated
    Sep 15, 2022
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Feb 26, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $481K in Sales Revenues for its fiscal quarter ending in September of 2022. Data for Vascular Biogenics | VBLT - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last February in 2025.

  6. T

    Vascular Biogenics | VBLT - Assets

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2023
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2023). Vascular Biogenics | VBLT - Assets [Dataset]. https://tradingeconomics.com/vblt:us:assets
    Explore at:
    csv, excel, xml, jsonAvailable download formats
    Dataset updated
    Sep 15, 2023
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 27, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $20.94M in Assets for its fiscal quarter ending in September of 2023. Data for Vascular Biogenics | VBLT - Assets including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  7. T

    Vascular Biogenics | VBLT - Employees Total Number

    • tradingeconomics.com
    • cdn.tradingeconomics.com
    csv, excel, json, xml
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS, Vascular Biogenics | VBLT - Employees Total Number [Dataset]. https://tradingeconomics.com/vblt:us:employees
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 15, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported 7 in Employees for its fiscal year ending in December of 2022. Data for Vascular Biogenics | VBLT - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  8. T

    Vascular Biogenics | VBLT - Interest Expense On Debt

    • cdn.tradingeconomics.com
    • tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2023). Vascular Biogenics | VBLT - Interest Expense On Debt [Dataset]. https://cdn.tradingeconomics.com/vblt:us:interest-expense-on-debt
    Explore at:
    xml, csv, excel, jsonAvailable download formats
    Dataset updated
    Sep 15, 2023
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 20, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $63K in Interest Expense on Debt for its fiscal quarter ending in September of 2023. Data for Vascular Biogenics | VBLT - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  9. T

    Vascular Biogenics | VBLT - EPS Earnings Per Share

    • tradingeconomics.com
    • cdn.tradingeconomics.com
    csv, excel, json, xml
    Updated Sep 15, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2023). Vascular Biogenics | VBLT - EPS Earnings Per Share [Dataset]. https://tradingeconomics.com/vblt:us:eps
    Explore at:
    json, xml, excel, csvAvailable download formats
    Dataset updated
    Sep 15, 2023
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Mar 27, 2025
    Area covered
    United States
    Description

    Vascular Biogenics reported $-0.48 in EPS Earnings Per Share for its fiscal quarter ending in September of 2023. Data for Vascular Biogenics | VBLT - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last March in 2025.

  10. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
TRADING ECONOMICS (2024). Vascular Biogenics | VBLT - Market Capitalization [Dataset]. https://cdn.tradingeconomics.com/vblt:us:market-capitalization

Vascular Biogenics | VBLT - Market Capitalization

Explore at:
excel, json, csv, xmlAvailable download formats
Dataset updated
May 23, 2024
Dataset authored and provided by
TRADING ECONOMICS
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Jan 1, 2000 - Mar 12, 2025
Area covered
United States
Description

Vascular Biogenics reported $12.7M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.Data for Vascular Biogenics | VBLT - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last March in 2025.

Search
Clear search
Close search
Google apps
Main menu